인쇄하기
취소
|
Boehringer Ingelheim was given corrective measures to its dispose assets related to sales of its porcine circovirus vaccine and oral nonsteroidal anti-inflammatory drug(NSAID) for use in dogs in Korea.
On the 23rd, the Fair Trade Commission(Chairman Jae-Chan Jeong, FTC) announced it decided to impose the corrective measures that include disposal of assets on sales of its porcine circovirus vac...